Speakers
Daniel J. Lenihan, DrMed, FACC
Director, Cardiovascular Clinical Research; Prof, Div. Cardiovascular Medicine, Vanderbilt University, United States
Dr Lenihan is the Director of Clinical Research for Cardiovascular Medicine at Vanderbilt University. He has been involved in clinical research in cardiology, specifically heart failure and cardio-oncology for nearly 20 years. He is the US based president of the International CardiOncology Society
John K. Finkle, MD, FACC, FACP
Vice President, Global Clinical Safety and Pharmacovigilance, GlaxoSmithKline, United States
Dr. Finkle is boarded in Internal Medicine, Cardiology and Clinical Cardiac Electrophysiology. He works in the Clinical Safety Department at GSK and is Chair of the Global QT and Cardiology Safety Panels. Dr. Finkle also sits on Executive Steering Committee of the Cardiac Safety Research Consortia
Juan Carlos Plana, MD
Cardiovascular Staff Physician, Cleveland Clinic, United States
Mary Beth Sabol, MD
, Glaxosmithkline, United States
Philip T. Sager, MD
Adjunct Professor, Stanford University, United States
Philip T. Sager, M.D, FACC, FAHA, FHRS is an Adjunct Professor at the Stanford University, the previous chair of the FDA Cardio-Renal Advisory Committee and an Executive Comm. member of the Cardiac Safety Research Consortium. He is a member of the ICH E14 QT Group and is on the Steering Comm, Comprehensive In Vitro Proarrhythmia Assay effort. He holds an M.D. from Yale University and B.S. degrees in biology and chemistry from the MIT and has published more than 200 manuscripts and abstracts.
Joseph R Carver, DrMed
Senior Administrative Officer, Abramson Cancer Center, United States
Have an account?